{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:13:46Z","timestamp":1787163226060,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1038\/s41388-018-0512-9","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T05:47:20Z","timestamp":1538113640000},"page":"1381-1397","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The interaction of Lin28A\/Rho associated coiled-coil containing protein kinase2 accelerates the malignancy of ovarian cancer"],"prefix":"10.1038","volume":"38","author":[{"given":"Yancheng","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingpin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanqin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cijun","family":"Shuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuping","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,28]]},"reference":[{"key":"512_CR1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"512_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ygyno.2017.08.028","volume":"147","author":"M Pisu","year":"2017","unstructured":"Pisu M, Kenzik KM, Rim SH, Funkhouser EM, Bevis KS, Alvarez RD, et al. Values and worries of ovarian cancer patients. Gynecol Oncol. 2017;147:433\u20138.","journal-title":"Gynecol Oncol"},{"key":"512_CR3","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","volume":"166","author":"H Zhang","year":"2016","unstructured":"Zhang H, Liu T, Zhang Z, Payne SH, Zhang B, McDermott JE, et al. Integrated proteogenomic characterization of human High-Grade serous ovarian cancer. Cell. 2016;166:755\u201365.","journal-title":"Cell"},{"key":"512_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.cell.2017.07.025","volume":"170","author":"A Jimenez-Sanchez","year":"2017","unstructured":"Jimenez-Sanchez A, Memon D, Pourpe S, Veeraraghavan H, Li Y, Vargas HA, et al. Heterogeneous Tumor-Immune microenvironments among differentially growing metastases in an ovarian cancer patient. Cell. 2017;170:927.","journal-title":"Cell"},{"key":"512_CR5","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1097\/IGC.0000000000000828","volume":"26","author":"Y Zhong","year":"2016","unstructured":"Zhong Y, Gao D, He S, Shuai C, Peng S. Dysregulated expression of long noncoding RNAs in ovarian cancer. Int J Gynecol Cancer. 2016;26:1564\u201370.","journal-title":"Int J Gynecol Cancer"},{"key":"512_CR6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ygyno.2013.01.009","volume":"129","author":"JA Rauh-Hain","year":"2013","unstructured":"Rauh-Hain JA, Nitschmann CC Jr., Worley MJ, Bradford LS, Berkowitz RS, Schorge JO, et al. Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Gynecol Oncol. 2013;129:63\u20138.","journal-title":"Gynecol Oncol"},{"key":"512_CR7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.8372","volume":"31","author":"K Cheng","year":"2013","unstructured":"Cheng K, Shapira I, Rosen LM, John VS, Lovecchio JL, Menzin A. et al. Correlation of in vitro chemotherapy drug resistance assay to clinical response to carboplatin and paclitaxel combination chemotherapy in ovarian carcinoma. J Clin Oncol. 2013;31:e16546","journal-title":"J Clin Oncol"},{"key":"512_CR8","first-page":"74","volume":"70","author":"I Wertel","year":"2017","unstructured":"Wertel I, Okla K, Surowka J, Bilska M, Polak G, Bednarek W, et al. [Why ovarian cancer cells escape from immune surveillance?]. Wiad Lek. 2017;70:74\u201380.","journal-title":"Wiad Lek"},{"key":"512_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.cell.2010.02.007","volume":"140","author":"SR Viswanathan","year":"2010","unstructured":"Viswanathan SR, Daley GQ. Lin28: A microRNA regulator with a macro role. Cell. 2010;140:445\u20139.","journal-title":"Cell"},{"key":"512_CR10","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.cell.2011.10.020","volume":"147","author":"Y Nam","year":"2011","unstructured":"Nam Y, Chen C, Gregory RI, Chou JJ, Sliz P. Molecular basis for interaction of let-7 microRNAs with Lin28. Cell. 2011;147:1080\u201391.","journal-title":"Cell"},{"key":"512_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/ng.392","volume":"41","author":"SR Viswanathan","year":"2009","unstructured":"Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet. 2009;41:109\u2013843.","journal-title":"Nat Genet"},{"key":"512_CR12","doi-asserted-by":"publisher","first-page":"21310","DOI":"10.1074\/jbc.C800108200","volume":"283","author":"E Piskounova","year":"2008","unstructured":"Piskounova E, Viswanathan SR, Janas M, LaPierre RJ, Daley GQ, Sliz P, et al. Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. J Biol Chem. 2008;283:21310\u20134.","journal-title":"J Biol Chem"},{"key":"512_CR13","doi-asserted-by":"publisher","first-page":"41961","DOI":"10.1074\/jbc.M110.169607","volume":"285","author":"X Zhong","year":"2010","unstructured":"Zhong X, Li N, Liang S, Huang Q, Coukos G, Zhang L. Identification of MicroRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells. J Biol Chem. 2010;285:41961\u201371.","journal-title":"J Biol Chem"},{"key":"512_CR14","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/onc.2009.500","volume":"29","author":"S Peng","year":"2010","unstructured":"Peng S, Maihle NJ, Huang Y. Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer. Oncogene. 2010;29:2153\u20139.","journal-title":"Oncogene"},{"key":"512_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cm.20472","volume":"67","author":"M Amano","year":"2010","unstructured":"Amano M, Nakayama M, Kaibuchi K. Rho-kinase\/ROCK: A key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken). 2010;67:545\u201354.","journal-title":"Cytoskeleton (Hoboken)"},{"key":"512_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1247\/csf.12018","volume":"37","author":"M Iizuka","year":"2012","unstructured":"Iizuka M, Kimura K, Wang S, Kato K, Amano M, Kaibuchi K, et al. Distinct distribution and localization of rho-kinase in mouse epithelial, muscle and neural tissues. Cell Struct Funct. 2012;37:155\u201375.","journal-title":"Cell Struct Funct"},{"key":"512_CR17","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nrm1128","volume":"4","author":"K Riento","year":"2003","unstructured":"Riento K, Ridley AJ. Rocks: Multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol. 2003;4:446\u201356.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"512_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0014-5793(96)00811-3","volume":"392","author":"O Nakagawa","year":"1996","unstructured":"Nakagawa O, Fujisawa K, Ishizaki T, Saito Y, Nakao K, Narumiya S. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine\/threonine kinase in mice. FEBS Lett. 1996;392:189\u201393.","journal-title":"FEBS Lett"},{"key":"512_CR19","doi-asserted-by":"publisher","first-page":"4434","DOI":"10.1128\/MCB.00577-13","volume":"33","author":"T Yugawa","year":"2013","unstructured":"Yugawa T, Nishino K, Ohno S, Nakahara T, Fujita M, Goshima N, et al. Noncanonical NOTCH signaling limits self-renewal of human epithelial and induced pluripotent stem cells through ROCK activation. Mol Cell Biol. 2013;33:4434\u201347.","journal-title":"Mol Cell Biol"},{"key":"512_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.ceb.2008.01.002","volume":"20","author":"MF Olson","year":"2008","unstructured":"Olson MF. Applications for ROCK kinase inhibition. Curr Opin Cell Biol. 2008;20:242\u20138.","journal-title":"Curr Opin Cell Biol"},{"key":"512_CR21","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/hep.22836","volume":"49","author":"CC Wong","year":"2009","unstructured":"Wong CC, Wong C, Tung EK, Man K, Ng IO. Rho-Kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion. Hepatology. 2009;49:1583\u201394.","journal-title":"Hepatology"},{"key":"512_CR22","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.yexcr.2012.04.017","volume":"318","author":"T Liu","year":"2012","unstructured":"Liu T, Yu X, Li G, Yuan R, Wang Q, Tang P, et al. Rock2 regulates Cdc25A through ubiquitin proteasome system in hepatocellular carcinoma cells. Exp Cell Res. 2012;318:1994\u20132003.","journal-title":"Exp Cell Res"},{"key":"512_CR23","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3727\/096504010X12767359113767","volume":"18","author":"ME Kalender","year":"2010","unstructured":"Kalender ME, Demiryurek S, Oztuzcu S, Kizilyer A, Demiryurek AT, Sevinc A, et al. Association between the Thr431Asn polymorphism of the ROCK2 gene and risk of developing metastases of breast cancer. Oncol Res. 2010;18:583\u201391.","journal-title":"Oncol Res"},{"key":"512_CR24","first-page":"658S","volume":"693","author":"ME Kalender","year":"2009","unstructured":"Kalender ME, Demiryurek S, Oztuzcu S, Kizilyer A, Demiryurek AT, Sevinc A, et al. Association between the thr431asn polymorphism of the rock2 gene and breast cancer. Cancer Res. 2009;693:658S.","journal-title":"Cancer Res"},{"key":"512_CR25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1517\/14728222.2012.715149","volume":"16","author":"QM Wang","year":"2012","unstructured":"Wang QM, Liao JK. ROCKs as immunomodulators of stroke. Expert Opin Ther Targets. 2012;16:1013\u201325.","journal-title":"Expert Opin Ther Targets"},{"key":"512_CR26","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1101\/gad.415007","volume":"21","author":"A Polesskaya","year":"2007","unstructured":"Polesskaya A, Cuvellier S, Naguibneva I, Duquet A, Moss EG, Harel-Bellan A. Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Gene Dev. 2007;21:1125\u201338.","journal-title":"Gene Dev"},{"key":"512_CR27","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2559.2011.03949.x","volume":"59","author":"D Xue","year":"2011","unstructured":"Xue D, Peng Y, Wang F, Allan RW, Cao D. RNA-binding protein LIN28 is a sensitive marker of ovarian primitive germ cell tumours. Histopathology. 2011;59:452\u20139.","journal-title":"Histopathology"},{"key":"512_CR28","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.mce.2012.10.025","volume":"365","author":"A Grieco","year":"2013","unstructured":"Grieco A, Rzeczkowska P, Alm C, Palmert MR. Investigation of peripubertal expression of Lin28a and Lin28b in C57BL\/6 female mice. Mol Cell Endocrinol. 2013;365:241\u20138.","journal-title":"Mol Cell Endocrinol"},{"key":"512_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/bjc.2015.254","volume":"113","author":"K Hsu","year":"2015","unstructured":"Hsu K, Shen M, Huang Y, Cheng Y, Lin S, Chow N, et al. Overexpression of the RNA-binding proteins Lin28B and IGF2BP3 (IMP3) is associated with chemoresistance and poor disease outcome in ovarian cancer. Brit J Cancer. 2015;113:414\u201324.","journal-title":"Brit J Cancer"},{"key":"512_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1154040","volume":"320","author":"SR Viswanathan","year":"2008","unstructured":"Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science. 2008;320:97\u2013100.","journal-title":"Science"},{"key":"512_CR31","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.neuroscience.2013.06.023","volume":"248","author":"MIH Bhuiyan","year":"2013","unstructured":"Bhuiyan MIH, Lee JH, Kim SY, Cho KO. Expression of exogenous lin28 contributes to proliferation and survival of mouse primary cortical neurons in vitro. Neuroscience. 2013;248:448\u201358.","journal-title":"Neuroscience"},{"key":"512_CR32","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1038\/onc.2012.340","volume":"32","author":"A Ben-Shmuel","year":"2013","unstructured":"Ben-Shmuel A, Shvab A, Gavert N, Brabletz T, Ben-Ze\u2019Ev A. Global analysis of L1-transcriptomes identified IGFBP-2 as a target of ezrin and NF-kappa B signaling that promotes colon cancer progression. Oncogene. 2013;32:3220\u201330.","journal-title":"Oncogene"},{"key":"512_CR33","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1158\/0008-5472.CAN-12-0954","volume":"72","author":"RA Patel","year":"2012","unstructured":"Patel RA, Forinash KD, Pireddu R, Sun Y, Sun N, Martin MP, et al. RKI-1447 is a potent inhibitor of the Rho-Associated ROCK kinases with Anti-Invasive and antitumor activities in breast cancer. Cancer Res. 2012;72:5025\u201334.","journal-title":"Cancer Res"},{"key":"512_CR34","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1158\/1078-0432.CCR-11-3313","volume":"18","author":"TA Yap","year":"2012","unstructured":"Yap TA, Walton MI, Grimshaw KM, Te Poele RH, Eve PD, Valenti MR, et al. AT13148 is a novel, oral Multi-AGC kinase inhibitor with potent pharmacodynamic and antitumor activity. Clin Cancer Res. 2012;18:3912\u201323.","journal-title":"Clin Cancer Res"},{"key":"512_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.5487\/TR.2010.26.4.245","volume":"26","author":"H Son","year":"2010","unstructured":"Son H, Moon A. Epithelial-mesenchymal transition and cell invasion. Toxicol Res. 2010;26:245\u201352.","journal-title":"Toxicol Res"},{"key":"512_CR36","doi-asserted-by":"crossref","first-page":"651","DOI":"10.18632\/oncotarget.199","volume":"1","author":"I Zlobec","year":"2010","unstructured":"Zlobec I, Lugli A. Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget. Oncotarget. 2010;1:651\u201361.","journal-title":"Oncotarget"},{"key":"512_CR37","doi-asserted-by":"publisher","first-page":"3977","DOI":"10.1242\/jcs.00089","volume":"115","author":"J Huelsken","year":"2002","unstructured":"Huelsken J, Behrens J. The Wnt signalling pathway. J Cell Sci. 2002;115:3977\u20138.","journal-title":"J Cell Sci"},{"key":"512_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1053\/j.gastro.2010.10.006","volume":"140","author":"CC Wong","year":"2011","unstructured":"Wong CC, Wong CM, Tung EK, Au SL, Lee JM, Poon RT, et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by downregulating Rho-kinase 2. Gastroenterology. 2011;140:322\u201331.","journal-title":"Gastroenterology"},{"key":"512_CR39","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3892\/ijo.2016.3539","volume":"49","author":"GL Song","year":"2016","unstructured":"Song GL, Jin CC, Zhao W, Tang Y, Wang YL, Li M, et al. Regulation of the RhoA\/ROCK\/AKT\/beta-catenin pathway by arginine-specific ADP-ribosytransferases 1 promotes migration and epithelial\u2013mesenchymal transition in colon carcinoma. Int J Oncol. 2016;49:646\u201356.","journal-title":"Int J Oncol"},{"key":"512_CR40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.brainres.2012.11.034","volume":"1492","author":"S Boku","year":"2013","unstructured":"Boku S, Nakagawa S, Toda H, Kato A, Takamura N, Omiya Y, et al. ROCK2 regulates bFGF-induced proliferation of SH-SY5Y cells through GSK-3beta and beta-catenin pathway. Brain Res. 2013;1492:7\u201317.","journal-title":"Brain Res"},{"key":"512_CR41","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1158\/0008-5472.CAN-11-2373","volume":"72","author":"D Vigil","year":"2012","unstructured":"Vigil D, Kim TY, Plachco A, Garton AJ, Castaldo L, Pachter JA, et al. ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion. Cancer Res. 2012;72:5338\u201347.","journal-title":"Cancer Res"},{"key":"512_CR42","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/wrna.1112","volume":"3","author":"Y Huang","year":"2012","unstructured":"Huang Y. A mirror of two faces: Lin28 as a master regulator of both miRNA and mRNA. Wiley Interdiscip Rev RNA. 2012;3:483\u201394.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"512_CR43","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, et al. Identification of the tumour transition states occurring during EMT. Nature. 2018;556:463\u20138.","journal-title":"Nature"},{"key":"512_CR44","doi-asserted-by":"publisher","first-page":"5287","DOI":"10.1158\/0008-5472.CAN-14-0284","volume":"74","author":"R Yuan","year":"2014","unstructured":"Yuan R, Wang K, Hu J, Yan C, Li M, Yu X, et al. Ubiquitin-like protein FAT10 promotes the invasion and metastasis of hepatocellular carcinoma by modifying beta-Catenin degradation. Cancer Res. 2014;74:5287\u2013300.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0512-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0512-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-018-0512-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:13:59Z","timestamp":1684602839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-018-0512-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,28]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["512"],"URL":"https:\/\/doi.org\/10.1038\/s41388-018-0512-9","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,28]]},"assertion":[{"value":"4 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}